Obesity as Unhealthy as Heart Failure -Study
Nov 08, 2004
Very obese people are as unhealthy, and probably as likely to die, as patients with heart failure, U.S. researchers reported on Sunday.

US FDA to Review Post-Market Safety Checks
Nov 07, 2004
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.

Pre-Pregnancy Multivitamins Prevent Prematurity
Nov 06, 2004
Women who take multivitamins before becoming pregnant are less likely to give birth to premature babies, new study findings suggest.

Hopes Up for Sanofi Obesity Drug, 2-Year Data Eyed
Nov 05, 2004
Expectations rose for Sanofi-Aventis's big new drug hope Acomplia on Friday as the French firm revealed it would present two-year, rather than one-year, data on the anti-obesity medicine next week.

Experiment Stretches Flu Vaccine for Healthy
Nov 04, 2004
It might be possible to stretch out the scarce U.S. supply of flu vaccine by diluting it and injecting it differently, U.S. researchers said on Wednesday.

Calif. Voters Back $3 Billion Stem Cell Measure
Nov 03, 2004
A controversial California ballot measure that would fund a decade of stem cell research with $3 billion in state money was headed for a resounding victory on Wednesday, initial returns showed.

Coffee, Cigarette Combo Is Extra Hard on Arteries
Nov 02, 2004
People who like to start the day with coffee and a cigarette may be doing particular damage to their arteries, new research suggests.

Grumpy British Bosses Need More Sleep -Study
Nov 01, 2004
A quarter of Britain's bosses are likely to be in a bad mood at work because of too little sleep, research released on Monday showed.

Despite Vaccines, Whooping Cough Creeps Back
Oct 31, 2004
Whooping cough is making a comeback 40 years after most industrialized countries started vaccinating children, and the culprit seems to be weakening effects of the shot, researchers said on Saturday.

Novartis Breast Cancer Drug OK'd for Wider U.S. Use
Oct 30, 2004
Novartis AG won U.S. approval to promote the drug Femara for women who have finished standard therapy for early-stage breast cancer and run out of options, the company said on Friday.